Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1CNS 1

Conditions

Hodgkin Disease 37Lymphoma 27Urinary Bladder Neoplasms 9Melanoma 7Carcinoma, Non-Small-Cell Lung 4Urethral Neoplasms 3Prostatic Neoplasms 3Lung Neoplasms 3Skin Neoplasms 2Oligodendroglioma 2Neurofibromatosis 1 2Neoplasms 2Lymphoma, Large-Cell, Anaplastic 2Leukemia 2HIV Infections 2Glioma 2Central Nervous System Neoplasms 2Brain Neoplasms 2Astrocytoma 2Uterine Cervical Neoplasms 1Urothelial Carcinoma of the Bladder 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Survival Without Progression 1Sarcoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Optic Nerve Glioma 1Neurofibroma, Plexiform 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms × Vinblastine × Clear all
NCT01031420 2019-09-17

Dose Dense MVAC for Muscle Invasive Bladder Cancer

Fox Chase Cancer Center

Phase 2 Completed
54 enrolled 7 charts
Tumor-Agnostic

Neoplasms

NCT00213278 2014-11-20

Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma

The Hospital for Sick Children

Phase 2 Completed
50 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡